{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T19:10:42Z","timestamp":1695496242943},"reference-count":23,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T00:00:00Z","timestamp":1424390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabet. Med."],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To analyse the association of self\u2010monitoring of urine glucose with HbA<jats:sub>1c<\/jats:sub> concentration in people with Type 2 diabetes not treated with insulin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We studied the association of postprandial self\u2010monitored urine glucose with HbA<jats:sub>1c<\/jats:sub> concentrations in 264 people with Type 2 diabetes (mean age 62.4\u00a0years, time since diagnosis of diabetes 6.8\u00a0years and HbA<jats:sub>1c<\/jats:sub> 50\u00a0mmol\/l). All patients took part in a diabetes treatment and teaching programme. HbA<jats:sub>1c<\/jats:sub> values were adjusted according to the Diabetes Control and Complication Trial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean (\u00a0\u00b1\u00a0<jats:sc>sd<\/jats:sc>) HbA<jats:sub>1c<\/jats:sub> concentration for the patients with constant negative urine glucose tests (56.1% of patients) was 46 (\u00a0\u00b1\u00a06) mmol\/mol [6.4 (\u00a0\u00b1\u00a00.6)%]. This was significantly lower than in patients with &lt; 50% positive urine glucose tests (33.3% of patients): mean (\u00a0\u00b1\u00a0<jats:sc>sd<\/jats:sc>) HbA<jats:sub>1c<\/jats:sub> was 53 (\u00a0\u00b1\u00a08) mmol\/mol [7.0(\u00a0\u00b1\u00a00.7)%] and also lower than in patients with \u226550% positive tests (10.6% of patients): mean (\u00a0\u00b1\u00a0<jats:sc>sd<\/jats:sc>) HbA<jats:sub>1c<\/jats:sub> of 57 (\u00a0\u00b1\u00a08) mmol\/mol [7.4 (\u00a0\u00b1\u00a00.7)%]; <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.001. There was a significant correlation between the urine glucose test results and HbA<jats:sub>1c<\/jats:sub> (<jats:italic>r\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0.416; <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>HbA<jats:sub>1c<\/jats:sub> concentrations were observed to be in the near\u2010normal range for people with Type 2 diabetes not receiving insulin treatment who were negative for postprandial glucosuria. Urine glucose self\u2010monitoring is a cheap and effective method to determine the quality of glucose control.<\/jats:p><\/jats:sec>","DOI":"10.1111\/dme.12718","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T13:14:26Z","timestamp":1423314866000},"page":"958-962","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Postprandial self\u2010monitoring of urine glucose reflects glycaemic control in people with relatively well controlled Type 2 diabetes mellitus not treated with insulin: a retrospective cohort study"],"prefix":"10.1111","volume":"32","author":[{"given":"N.","family":"M\u00fcller","sequence":"first","affiliation":[{"name":"Jena University Hospital Department of Internal Medicine III Jena Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"K\u00e4mmer","sequence":"additional","affiliation":[{"name":"Jena University Hospital Department of Internal Medicine III Jena Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kloos","sequence":"additional","affiliation":[{"name":"Jena University Hospital Department of Internal Medicine III Jena Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Wolf","sequence":"additional","affiliation":[{"name":"Jena University Hospital Department of Internal Medicine III Jena Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U. A.","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Jena University Hospital Department of Internal Medicine III Jena Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,2,20]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90595-8"},{"key":"e_1_2_8_3_1","unstructured":"Federal Law Gazette 2009 Nr. 35 Part I: Twentieth Regulation amending Regulation risk structure compensation. June2009. Available athttp:\/\/www.g-ba.de\/downloads\/62-492-353\/2009-07-01-RSAV20.pdfLast accessed 5 July 2013."},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta14120"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e486"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1995.tb00491.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S28505"},{"issue":"1","key":"e_1_2_8_8_1","first-page":"i","article-title":"Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"32","author":"Canadian Diabetes Association","year":"2008","journal-title":"Can J Diabetes [Internet]"},{"key":"e_1_2_8_9_1","unstructured":"Scottish Intercollegiate Guidelines Network(2010)Management of diabetes. A national clinical guideline. Available athttp:\/\/www.sign.ac.uk\/pdf\/sign116.pdfLast accessed 4 July 2013."},{"key":"e_1_2_8_10_1","unstructured":"IDF Global Guidelines for Type 2 Diabetes2012. Available athttp:\/\/www.idf.org\/sites\/default\/files\/IDF-Guideline-for-Type-2-Diabetes.pdfLast accessed 28 June 2013."},{"key":"e_1_2_8_11_1","unstructured":"NICE clinical guideline 87: Type 2 diabetes: The management of type 2 diabetes. Update2010. Available athttp:\/\/www.nice.org.uk\/nicemedia\/live\/12165\/44320\/44320.pdfLast accessed 5 July 2013."},{"key":"e_1_2_8_12_1","unstructured":"German Medical Association National Association of Statutory Health Insurance Physicians Association of the Scientific Medical Societies in Germany.National guidelines Therapy of type 2 diabetes \u2013 long version. Version 2.2013. Available athttp:\/\/www.versorgungsleitlinien.de\/themen\/diabetes2\/dm2_therapie\/pdf\/NVL-DM2-Ther-lang-2.pdfLast accessed 2 October 2013."},{"issue":"2","key":"e_1_2_8_13_1","first-page":"B29","article-title":"Intensified treatment and education of type\u20101 diabetes mellitus as clinical routine: A nation\u2010wide quality\u2010circle experience in Germany","volume":"22","author":"M\u00fcller UA","year":"1999","journal-title":"Diabetes Care"},{"key":"e_1_2_8_14_1","first-page":"629","article-title":"Assessing Social Inequality in Microcensus Data and German National Health Examination Survey","volume":"65","author":"Dulon M","year":"2003","journal-title":"Gesundheitswesen"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39022.462546.80"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cms071"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1470"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.235"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2004.01286.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.13.10.1044"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.1960110109"},{"key":"e_1_2_8_22_1","unstructured":"Institute for Quality and Efficiency in Health Care (IQWIG).Urine\u2010 and blood glucose self monitoring in type diabetes. 14.10.2009 Version 1.0.Available athttps:\/\/www.iqwig.de\/download\/A0508_Abschlussbericht_Zuckerselbstmessung_bei_Diabetes_mellitus_Typ_2.pdfLast accessed 16 July 2012."},{"issue":"1","key":"e_1_2_8_23_1","first-page":"S391","article-title":"Postprandial urine tests for glucose \u2013 a reliable, painless and inexpensive monitoring of metabolic control in type 2 diabetes without insulin treatment","volume":"54","author":"M\u00fcller N","year":"2011","journal-title":"Diabetologia"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12598"}],"container-title":["Diabetic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdme.12718","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dme.12718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T18:42:21Z","timestamp":1695494541000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dme.12718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,20]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1111\/dme.12718"],"URL":"https:\/\/doi.org\/10.1111\/dme.12718","archive":["Portico"],"relation":{},"ISSN":["0742-3071","1464-5491"],"issn-type":[{"value":"0742-3071","type":"print"},{"value":"1464-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,20]]},"assertion":[{"value":"2015-02-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-02-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}